Detection of Human Cytomegalovirus UL97 D605E Mutation in Korean Stem Cell Transplantation Recipients and Donors |
Lee, Gyu-Cheol
(Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Choi, Su-Mi (Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Lee, Chan Hee (Department of Microbiology, College of Natural Sciences, Chungbuk National University) Lee, Dong-Gun (Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Choi, Jung-Hyun (Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Yoo, Jin-Hong (Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) |
1 | Jabs DA, Enger C, Dunn JP, Forman M. 1998. Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group. J. Infect. Dis. 177: 770-773. DOI ScienceOn |
2 | Erice A, Chou S, Biron KK, Stanat SC, Balfour Jr HH, Jordan MC. 1989. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N. Engl. J. Med. 320: 289-293. DOI ScienceOn |
3 | Hanks SK, Quinn AM, Hunter T. 1988. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241: 42-52. DOI |
4 | Ijichi O, Michel D, Mertens T, Miyata K, Eizuru Y. 2002. GCV resistance due to the mutation A594P in the cytomegalovirus protein UL97 is partially reconstituted by a second mutation at D605E. Antiviral Res. 53: 135-142. DOI ScienceOn |
5 | Lee GC, Lee DG, Choi SM, Yoo JH, Park SH, Choi JH, et al. 2005. Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir. J. Clin. Microbiol. 43: 5003-5008. DOI ScienceOn |
6 | Michel D, Höhn S, Haller T, Jun D, Mertens T. 2001. Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein. J. Med. Virol. 65: 70-76. DOI ScienceOn |
7 | Erice A, Gil-Roda C, Perez JL, Balfour HH, Sannerud KJ, Hanson MN, et al. 1997. Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. J. Infect. Dis. 175: 1087-1092. DOI ScienceOn |
8 | Chou S, Van Wechel LC, Lichy HM, Marousek GI. 2005. Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene. Antimicrob. Agents Chemother. 49: 2710-2715. DOI ScienceOn |
9 | Chou S, Erice A, Jordan MC, Vercellotti GM, Michels KR, Talarico CL, et al. 1995. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J. Infect. Dis. 171: 576-583. DOI ScienceOn |
10 | Chou S, Marousek G, Parenti DM, Gordon SM, LaVoy AG, Ross JG, et al. 1998. Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from three subjects receiving prolonged antiviral therapy. J. Infect. Dis. 178: 526-530. DOI ScienceOn |
11 | Chou S, Marousek G, Guentzel S, Follansbee SE, Poscher ME, Lalezari JP, et al. 1997. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. J. Infect. Dis. 176: 786-789. DOI ScienceOn |
12 | Chou S, Waldemer RH, Senters AE, Michels KS, Kemble GW, Miner RC, et al. 2002. Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir. J. Infect. Dis. 185: 162-169. DOI ScienceOn |
13 | Chou S, Guentzel S, Michels KR, Miner RC, Drew WL. 1995. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J. Infect. Dis. 172: 239-242. DOI ScienceOn |
14 | Sanchez Puch SI, Mathet VL, Porta M, Cuestas ML, Oubina JR, Videla CM, Salomon HE. 2009. Single and multiple mutations in the human cytomegalovirus UL97 gene and their relationship to the enzymatic activity of UL97 kinase for ganciclovir phosphorylation. Antiviral Res. 84: 194-198. DOI ScienceOn |
15 | Drew WL, Stempien MJ, Andrews J, Shadman A, Tan SJ, Miner R, et al. 1999. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir. J. Infect. Dis. 179: 1352-1355. DOI ScienceOn |
16 | Eckle T, Jahn G, Hamprecht K. 2003. High impact of an expanded restriction fragment length polymorphism assay on detection of ganciclovir-resistant UL97 mutants of human cytomegalovirus. Antimicrob. Agents Chemother. 47: 442-443. DOI |
17 | Alain S, Mazeron MC, Pepin JM, Bergmann JF, Narwa R, Raskine L, Sanson-Le Pors MJ. 1995. Value of a new rapid non-radioactive sequencing method for analysis of the cytomegalovirus UL97 gene in ganciclovir-resistant strains. J. Virol. Methods 51: 241-251. DOI ScienceOn |
18 | Centers for Disease Control and Prevention. 2000. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Recomm. Rep. 49(RR-10): 11-14. |
19 | Chou S. 2008. Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir. Rev. Med. Virol. 18: 233-246. DOI ScienceOn |
20 | Prix L, Hamprecht K, Holzhuter B, Handgretinger R, Klingebiel T, Jahn G. 1999. Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child. J. Infect. Dis. 180: 491-495. DOI ScienceOn |
21 | Sanchez Puch S, Ochoa C, Carballal G, Zala C, Cahn P, Brunet R, et al. 2004. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina. J. Clin. Virol. 30: 271-275. DOI ScienceOn |
22 | Smith IL, Cherrington JM, Jiles RE, Fuller MD, Freeman WR, Spector SA. 1997. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J. Infect. Dis. 176: 69-77. DOI ScienceOn |
23 | Tanaka K, Hori T, Yoto Y, Hatakeyama N, Yamamoto M, Suzuki N, Tsutsumi H. 2011. Human cytomegalovirus UL97 D605E polymorphism has a high prevalence in immunocompetent Japanese infants and children. Microbiol. Immunol. 55: 328-330. DOI ScienceOn |
24 | Zhou L, Fan J, Zheng SS, Ma WH. 2006. Prevalence of human cytomegalovirus UL97 D605E mutation in transplant recipients in China. Transplant. Proc. 38: 2926-2928. DOI ScienceOn |